Recommended Conferences

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: Validation by GC-MS and LC-MS

Author(s): Kakiyama G, Muto A, Takei H, Nittono H, Murai T, Kurosawa T, et al

Abstract

We have developed a simple and accurate HPLC method for measurement of fecal bile acids using phenacyl derivatives of unconjugated bile acids, and applied it to the measurement of fecal bile acids in cirrhotic patients. The HPLC method has the following steps: 1) lyophilization of the stool sample; 2) reconstitution in buffer and enzymatic deconjugation using cholylglycine hydrolase/sulfatase; 3) incubation with 0.1 N NaOH in 50% isopropanol at 60°C to hydrolyze esterified bile acids; 4) extraction of bile acids from particulate material using 0.1 N NaOH; 5) isolation of deconjugated bile acids by solid phase extraction; 6) formation of phenacyl esters by derivatization using phenacyl bromide; and 7) HPLC separation measuring eluted peaks at 254 nm. The method was validated by showing that results obtained by HPLC agreed with those obtained by LC-MS/MS and GC-MS. We then applied the method to measuring total fecal bile acid (concentration) and bile acid profile in samples from 38 patients with cirrhosis (17 early, 21 advanced) and 10 healthy subjects. Bile acid concentrations were significantly lower in patients with advanced cirrhosis, suggesting impaired bile acid synthesis.

Similar Articles

Gut microbiota role in dietary protein metabolism and health-related outcomes: The two sides of the coin

Author(s): Portune KJ, Beaumont M, Davila AM, Tomé D, Blachier F, Sanz Y

Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells

Author(s): Ignacio BJ, Olmo N, Perez-Ramos P, Santiago-Gómez A, Lecona E, Turnay J, et al

Intestinal bile acid physiology and pathophysiology

Author(s): Martínez-Augustin O, Sánchez de Medina F

Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis

Author(s): Martínez-Moya P, Romero-Calvo I, Requena P, Hernández-Chirlaque C, Aranda CJ, González R, et al

Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

Author(s): Dilger K, Hohenester S, Winkler-Budenhofer U, Bastiaansen BAJ, Schaap FG, Rust C, et al

Bile acids as carcinogens in human gastrointestinal cancers

Author(s): Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H

Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling

Author(s): Dossa AY, Escobar O, Golden J, Frey MR, Ford HF, Gayer CP

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

Author(s): Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

Author(s): Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IP, et al

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome

Author(s): Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, et al

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

Author(s): Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, et al